Interleukin 10 produced by macrophages inoculated with Mycobacterium avium attenuates mycobacteria-induced apoptosis by reduction of TNF-α activity

Journal of Infectious Diseases

Volumn 180, Issue 4, 1999, Pages 1230-1237

  Balcewicz Sablinska, M Katarzyna ^a   Gan, HuiXian ^a   Remold, Heinz G ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

APOPTOSIS; ARTICLE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HOST RESISTANCE; HUMAN; HUMAN CELL; MACROPHAGE; MYCOBACTERIOSIS; MYCOBACTERIUM AVIUM; NORMAL HUMAN; PRIORITY JOURNAL;

ANTIGENS, CD; APOPTOSIS; CELL SURVIVAL; CELLS, CULTURED; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-10; KINETICS; MACROPHAGES; MYCOBACTERIUM AVIUM COMPLEX; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033370663     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315011     Document Type: Article

References (44)

1. Horsburgh CR Jr, Mason UGD, Farhi DC, Iseman MD, Mason UG. Disseminated infection with Mycobacterium avium-intracellulare. A report of 13 cases and a review of the literature. Medicine 1985; 64:36-48.
2. Jacobson MA, Hopewell PC, Yajko DM, et al. Natural history of disseminated Mycobacterium avium complex infection in AIDS. J Infect Dis 1991;164:994-8.
3. Julander J, Hoffner S, Petrini B, Ostlund D, Multiple serovars of Mycobacterium avium complex in patients with AIDS. APMIS 1996; 104:318-20.
4. Crowle AJ, Tsang AY, Vatter AE, May MH. Comparison of 15 laboratory and patient-derived strains of Mycobacterium avium for ability to infect and multiply in cultured human macrophages. J Clin Microbiol 1986;24:812-21.
5. Fadok VA, Savill JS, Haslett C, et al. Different populations of macrophages use either the vitronectin receptor or the phosphatidylserine receptor to recognize and remove apoptotic cells. J Immunol 1992; 149:4029-35.
6. Fratazzi C, Arbeit RD, Carini C, Remold HG. Programmed cell death of Mycobacterium avium serovar 4-infected human macrophages prevents the mycobacteria from spreading and induces mycobacterial growth inhibition by freshly added, uninfected macrophages. J Immunol 1997; 158:4320-7.
7. Blanchard DK, Michelini-Norris MB, Friedman H, Djeu JY. Lysis of mycobacteria-infected monocytes by IL-2-activated killer cells: role of LFA-1. Cell Immunol 1989; 119:402-11.
8. Balcewicz-Sablinska MK, Keane J, Kornfeld H, Remold HG. Pathogenic Mycobacterium tuberculosis evades apoptosis of host macrophages by release of TNF-R2 resulting in inactivation of TNF-alpha. J Immunol 1998; 161:2636-41.
9. Gan H, Newman G, McCarthy PL, Remold HG. TNF-alpha response of human monocyte-derived macrophages to Mycobacterium avium, serovar 4, is of brief duration and protein kinase C dependent. J Immunol 1993; 150:2892-900.
10. Keane J, Balcewicz-Sablinska MK, Remold HG, et al. Infection by Mycobacterium tuberculosis promotes human alveolar macrophage apoptosis. Infect Immun 1997;65:298-304.
11. Vassalli P. The pathophysiology of tumor necrosis factors. Annu Rev Immunol 1992:10:411-52.
12. Bogdan C, Vodovotz Y, Nathan C. Macrophage deactivation by interleukin 10. J Exp Med 1991; 174:1549-55.
13. Capsoni F, Minonzio F, Ongari AM, Carbonelli V, Galli A, Zanussi C. Interleukin-10 down-regulates oxidative metabolism and antibody-dependent cellular cytotoxicity of human neutrophils. Scand J Immunol 1997;45:269-75.
14. Arai T, Hiromatsu K, Nishimura H, et al. Endogenous interleukin 10 prevents apoptosis in macrophages during Salmonella infection. Biochem Biophys Res Commun 1995:213:600-7.
15. Taga K, Chretien J, Cherncy B, Diaz L, Brown M, Tosato G. Interleukin-10 inhibits apoptotic cell death in infectious mononucleosis T cells. J Clin Invest 1994;94:251-60.
16. de Waal Malefyt R, Abrams J, Bennett B, Figdor, de Vries CE. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of JL-10 produced by monocytes. J Exp Med 1991; 174:1209-20.
17. Meylan PR, Richman DD, Kornbluth RS. Characterization and growth in human macrophages of Mycobacterium avium Complex strains isolated from the blood of patients with acquired immunodeficiency syndrome. Infect Immun 1990;58.2564-8.
18. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979;18:5294-9.
19. Sambrook J, Fritsch EF, Maniatis T. Transfer of denaturated RNA to nitrocellulose filters. In: C. Nolan, ed. Molecular Cloning, A Laboratory Manual, 2nd ed. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 1989: 746.
20. Feinberg AP, Yogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 1984; 137:266-7.
21. Flick DA, Gifford GE. Comparison of in vitro cell cytotoxic assays for tumor necrosis factor. J Immunol Methods 1984;68:167-75.
22. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992;119:493-501.
23. Newman GW, Gan HX, McCarthy PL Jr, Remold HG. Survival of human macrophages infected with Mycobacterium avium intracellulare correlates with increased production of tumor necrosis factor-αand IL-6. J Immunol 1991; 147:3942-8.
24. Gan HX, Newman GW, Remold HG. Plasminogen activator inhibitor type 2 prevents programmed cell death of human macrophages infected with Mycobacterium avium, serovar 4. J Immunol 1995; 155:1304-5.
25. Shiratsuchi H, Hamilton B, Toossi Z, Ellner JJ. Evidence against a role for interleukin-10 in the regulation of growth of Mycobacterium avium in human monocytes. J Infect Dis 1996; 173:410-7.
26. Vouldoukis I, Becherel A, Riveros-Moreno V, et al. Interleukin-10 and interleukin-4 inhibit intracellular killing of Leishmania infantum and Leishmania major by human macrophages by decreasing nitric oxide generation. Eur J Immunol 1997;27:860-5.
27. Fluckinger AC, Durand I, Banchereau J. Interleukin 10 induces apoptotic cell death of B-chronic lymphocytic leucemia cells. J Exp Med 1994; 179:91-9.
28. Wang P, Wu P, Siegel M.I, Egan RW, Billah MM. IL-10 inhibits transcription of cytokine genes in human peripheral blood mononuclear cells. J Immunol 1994; 153:811-6.
29. Seitz M, Loctscher P, Dewald B, Towbin H, Gallati H, Baggiolini M. Interleukin-10 differentially regulates cytokine inhibitor and chemokine release from blood mononuclear cells and fibroblasts. Eur J Immunol 1995;25:1129-32.
30. Joyce DA, Gibbons DP, Green P, Steer JH, Feldman M, Brennan FM. Two inhibitors of pro-inflammatory cytokine release, interleukin-10 and interleukin-4, have contrasting effects on release of soluble p75 tumor necrosis factor receptor by cultured monocytes. Eur J Immunol 1994;24:2699-705.
31. Linderholm M, Ahlm C, Settergren B, Waage A, Tarnvik A. Elevated plasma levels of tumor necrosis factor-alpha, soluble TNF receptors, interleukin-6, and interleukin-10 in patients with hemorrhagic fever with renal syndrome. J Infect Dis 1996;173:38-43.
32. Erb KJ, Kirman J, Delahunt B, Chen W, Le Gros G. IL-4, IL-5 and IL-10 are not required for the control of M. bovis-BCG infection in mice. Immunol Cell Biol 1998; 76:41-6.
33. Murray PJ, Wang L, Onufryk C, Tepper RI, Young RA. T cell-derived IL-10 antagonizes macrophage function in mycobacterial infection. J Immunol 1997; 158:315-21.
34. Murray PJ, Young RA. Increased antimycobacterial immunity in interleukin-10-deficient mice. Infect Immun 1999; 67:3087-95.
35. Bermudez LE, Champsi J. Infection with Mycobacterium avium induces production of interleukin-10 (IL-10), and administration of anti-IL-10 antibody is associated with enhanced resistance to infection in mice. Infect Immun 1993;61:3093-7.
36. Denis M, Ghadirian E. IL-10 neutralization augments mouse resistance to systemic Mycobacterium avium infections. J Immunol 1993;151:5425-30.
37. van der Poll T, Jannsen J, Levi M, ten Cate H, Wouter ten Cate J, van Deventer SJH. Regulation of interleukin 10 release by tumor necrosis factor in humans and chimpanzees. J Exp Med 1994, 180:1985-8.
38. Cassatella MA, Meda L, Bonora S, Ceska M, Constantin G. Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1 beta in mediating the production of IL-8 triggered by lipopolysaccharide. J Exp Med 1993; 178:2207-11.
39. Macatonia SE, Doherty TM, Knight SC, O'Garra A. Differential effect of IL-10 on dendritic cell-induced T cell proliferation and IFN-gamma production. J Immunol 1993:150:3755-65.
40. Ding L, Shevach EM. IL-10 inhibits mitogen-induced T cell proliferation by selectively inhibiting macrophage costimulatory function. J Immunol 1992; 148:3133-9.
41. Michelini-Norris MB, Blanchard DK. Differential release of interleukin(IL)-1 alpha, IL-1 beta, and IL-6 from normal human monocytes stimulated with a virulent and an avirulent isogenic variant of Mycobacterium avium-intracellulare strain. J Infect Dis 1992; 165:702-9.
42. Muller F, Aukrust P, Lien E, Haug CJ, Froland SS. Enhanced interleukin-10 production in response to Mycobacterium avium products in mononuclear cells from patients with human immunodeficiency virus infection. J Infect Dis 1998; 177:586-94.
43. de Jong R, Altare F, Haagen IA, et al. Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients. Science 1998;280:1435-8.
44. Gong JH, Zhang M, Modlin RL, et al. Interleukin-10 downregulates Mycobacterium tuberculosis-induced Thl responses and CTLA-4 expression. Infect Immun 1996; 64:913-8.